HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

5- ((2,4- dioxo- 5- thiazolidinyl)methyl)- 2- methoxy- N- ((4- (trifluoromethyl)phenyl)methyl)benzamide

an antihyperlipidemic agent that also functions as an insulin sensitizer, PPARalpha agonist, and PPARgamma agonist; structure in first source
Also Known As:
KCL1998001079; KRP 297; KRP-297; KRP297; L 410198; L-410198; L410198; MK 767; MK-767; MK767 cpd
Networked: 5 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dean, Dennis: 1 article (09/2006)
2. Franklin, Ronald B: 1 article (09/2006)
3. Jones, Allen N: 1 article (09/2006)
4. Kochansky, Christopher J: 1 article (09/2006)
5. Lasseter, Kenneth: 1 article (09/2006)
6. Rippley, Ronda K: 1 article (09/2006)
7. Schwartz, Jules: 1 article (09/2006)
8. Song, Hengchang: 1 article (09/2006)
9. Vincent, Stella H: 1 article (09/2006)
10. Wagner, John: 1 article (09/2006)

Related Diseases

1. Hyperglycemia
2. Insulin Resistance
3. Body Weight (Weight, Body)
4. Obesity
5. Type 2 Diabetes Mellitus (MODY)

Related Drugs and Biologics

1. Insulin (Novolin)
2. 2,4-thiazolidinedione (thiazolidinedione)
3. PPAR alpha
4. Peroxisome Proliferator-Activated Receptors (PPAR)
5. Triglycerides (Triacylglycerol)
6. Lipids
7. Glucose (Dextrose)
8. Bezafibrate
9. Troglitazone (Rezulin)
10. Pioglitazone (Actos)